NCT06174428 Validity of Viome's Oral/throat Cancer Test
| NCT ID | NCT06174428 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Viome |
| Condition | Oral and Throat Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-01-27 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-01-27 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A total of at least 1,000 participants with suspicion of cancer including at least 107 subjects who will be diagnosed with OSCC or OPSCC will be enrolled from either primary or secondary care centers in the U.S. Clinicians will use Viome collection kits to collect saliva samples from eligible patients.
Eligibility Criteria
Inclusion Criteria: * Signed and dated informed consent prior to any study-specific procedures are performed * Willing and able to follow the study instructions, as described in the recruitment letter * Adults (18 years old or older) * Suspicion of OSCC or OPSCC on clinical presentation by a clinician Exclusion Criteria: * Pregnancy * Use of fertility enhancing medications
Contact & Investigator
Cristina Julian
PRINCIPAL INVESTIGATOR
Viome
Frequently Asked Questions
Who can join the NCT06174428 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oral and Throat Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06174428 currently recruiting?
Yes, NCT06174428 is actively recruiting participants. Contact the research team at studies@viome.com for enrollment information.
Where is the NCT06174428 trial being conducted?
This trial is being conducted at St Louis, United States, Memphis, United States.
Who is sponsoring the NCT06174428 clinical trial?
NCT06174428 is sponsored by Viome. The principal investigator is Cristina Julian at Viome. The trial plans to enroll 1,000 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.